PTAB Sides With Amneal on Obviousness of Purdue’s Oxycontin Patent

Drug Industry Daily
A A
The PTO’s Patent Trial and Appeal Board ruled against a Purdue Pharma patent on OxyContin, agreeing with Amneal Pharmaceuticals on the patent’s obviousness.

To View This Article:

Login

Subscribe To Drug Industry Daily